These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33791219)

  • 1. Survival-Weighted Health Profiles in Nasopharyngeal Cancer Patients.
    Lai CH; Chen WC; Fang CC; Chen MF
    Front Oncol; 2021; 11():635667. PubMed ID: 33791219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of life expectancy and quality-adjusted life expectancy in non-metastatic nasopharyngeal cancer patients treated by intensity-modulated radiotherapy with or without chemotherapy.
    Lai CH; Chen MF; Fang FM; Chen WC
    Oral Oncol; 2014 Jul; 50(7):646-50. PubMed ID: 24747031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival-Weighted Health Profiles in Patients Treated for Advanced Oral Cavity Squamous Cell Carcinoma.
    Tsai YT; Chen WC; Hsu CM; Tsai MS; Chang GH; Lee YC; Huang EI; Fang CC; Lai CH
    Front Oncol; 2021; 11():754412. PubMed ID: 34660322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival-weighted quality of life profiles in patients treated for laryngeal and hypopharyngeal cancers.
    Tsai YT; Fang KH; Chen WC; De Vito A; Liao CT; Kang CJ; Hsu CM; Huang EI; Tsai MS; Chang GH; Lee YC; Lai CH
    J Cancer; 2024; 15(7):1805-1815. PubMed ID: 38434970
    [No Abstract]   [Full Text] [Related]  

  • 5. The lifetime burden following stroke: Long term impact of stroke on survival and quality of life.
    Cheon S; Li CY; Jeng JS; Wang JD; Ku LE
    Int J Stroke; 2023 Aug; 18(7):795-803. PubMed ID: 36912208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
    Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
    Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of Quality-Adjusted Life Expectancy of Patients With Oral Cancer: Integration of Lifetime Survival With Repeated Quality-of-Life Measurements.
    Chung CH; Hu TH; Wang JD; Hwang JS
    Value Health Reg Issues; 2020 May; 21():59-65. PubMed ID: 31655464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon.
    Lai WW; Chung CH; Lin CN; Yang SC; Hwang JS; Wang JD
    J Formos Med Assoc; 2021 Dec; 120(12):2089-2099. PubMed ID: 34020855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: Evidence from real world data.
    Chang KC; Lee KY; Lu TH; Hwang JS; Lin CN; Ting SY; Chang CC; Wang JD
    Drug Alcohol Depend; 2019 Aug; 201():197-204. PubMed ID: 31247504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a survey to estimate health expectancy and quality-adjusted life expectancy to assess inequalities in health and quality of life.
    Collins B
    Value Health; 2013 Jun; 16(4):599-603. PubMed ID: 23796294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.
    Huang TL; Tsai MH; Chuang HC; Chien CY; Lin YT; Tsai WL; Fang FM
    Radiat Oncol; 2020 Apr; 15(1):84. PubMed ID: 32307024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of work-related cancers in Taiwan-Estimation with QALY (quality-adjusted life year) and healthcare costs.
    Lee LJ; Lin CK; Hung MC; Wang JD
    Prev Med Rep; 2016 Dec; 4():87-93. PubMed ID: 27413666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.
    Fang FM; Chien CY; Tsai WL; Chen HC; Hsu HC; Lui CC; Huang TL; Huang HY
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):356-64. PubMed ID: 18355980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival-weighted health profile for long-term survivors of acute myelogenous leukemia.
    Hsu C; Wang JD; Hwang JS; Tien HF; Chang SM; Cheng AL; Chen YC; Tang JL
    Qual Life Res; 2003 Aug; 12(5):503-17. PubMed ID: 13677495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy.
    Zhao C; Chen J; Yu B; Chen X
    Int J Radiat Biol; 2014 Oct; 90(10):853-8. PubMed ID: 24758521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
    Bian X; Song T; Wu S
    Expert Rev Anticancer Ther; 2015 Jan; 15(1):109-19. PubMed ID: 25231774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of expected health impacts for major cancers: integration of incidence rate and loss of quality-adjusted life expectancy.
    Hung MC; Lai WW; Chen HH; Su WC; Wang JD
    Cancer Epidemiol; 2015 Feb; 39(1):126-32. PubMed ID: 25553846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: adjusting quality-of-life and lead-time bias for utility of surgery.
    Yang SC; Lai WW; Chang HY; Su WC; Chen HH; Wang JD
    Lung Cancer; 2014 Oct; 86(1):96-101. PubMed ID: 25178685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life as a Mediator between Cancer Stage and Long-Term Mortality in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Radiotherapy.
    Liao KC; Chuang HC; Chien CY; Lin YT; Tsai MH; Su YY; Yang CH; Lai CC; Huang TL; Li SH; Lee TF; Lin WT; Lee CH; Fang FM
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
    Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
    BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.